Bio-Chem, Koganei announce Opus solenoid actuated rocker valve

A co-development effort between Bio-Chem Fluidics and Koganei Corp. has resulted in the Opus solenoid actuated rocker valve – specifically designed for clinical diagnostics and life science applications.

Bio-Chem and Koganei announced the release of the Opus rocker valve on July 25. The Opus is a modification of the existing Koganei PVR valves. It is about half the size and 60% the volume of competitive valves while maintaining equivalent flow rates, according to Bio-Chem (Boonton, N.J.) and Koganie (U.S. headquarters in Fremont, Calif.).

Under real world conditions, an Opus valve is expected to have a life expectancy exceeding 10 million cycles.

The valve is the result of a five-year medical co-development partnership that Bio-Chem and Koganei entered into last year.

“This partnership will drive long term innovation specific to our targeted markets,” said William Easterbrook, VP of innovation and strategic marketing of Bio-Chem, in a news release.

“We are leveraging Bio-Chem’s presence and brand in life science markets with Koganei’s proven valve technology and world class automation capabilities to provide the desired outcomes for our OEM customers,” Easterbrook said. “Our goal is to create innovations to improve the quality of life through solutions that are clinically relevant and cost efficient.”

[Want to stay more on top of MDO content? Subscribe to our weekly e-newsletter.]

Theranos whistleblower Tyler Shultz to participate in keynote interview at DeviceTalks Boston At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos. Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston. REGISTER NOW